BAYER AG-REG (BAYN.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:BAYN - DE000BAY0017 - Common Stock
30.485 EUR
-0.14 (-0.44%)
Taking everything into account, BAYN scores 3 out of 10 in our fundamental rating. BAYN was compared to 55 industry peers in the Pharmaceuticals industry. BAYN may be in some trouble as it scores bad on both profitability and health. BAYN is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
BAYN had positive earnings in the past year.
In the past year BAYN had a positive cash flow from operations.
In multiple years BAYN reported negative net income over the last 5 years.
Each year in the past 5 years BAYN had a positive operating cash flow.
1.2 Ratios
BAYN has a worse Return On Assets (-3.25%) than 63.64% of its industry peers.
The Return On Equity of BAYN (-11.25%) is worse than 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROIC | N/A |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Operating Margin of BAYN has declined.
BAYN has a worse Gross Margin (54.95%) than 69.09% of its industry peers.
In the last couple of years the Gross Margin of BAYN has declined.
BAYN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
BAYN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for BAYN remains at a similar level compared to 5 years ago.
The debt/assets ratio for BAYN has been reduced compared to a year ago.
2.2 Solvency
BAYN has an Altman-Z score of 0.81. This is a bad value and indicates that BAYN is not financially healthy and even has some risk of bankruptcy.
BAYN has a Altman-Z score of 0.81. This is in the lower half of the industry: BAYN underperforms 74.55% of its industry peers.
BAYN has a debt to FCF ratio of 8.37. This is a slightly negative value and a sign of low solvency as BAYN would need 8.37 years to pay back of all of its debts.
BAYN has a worse Debt to FCF ratio (8.37) than 65.45% of its industry peers.
BAYN has a Debt/Equity ratio of 1.04. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BAYN (1.04) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Altman-Z | 0.81 |
ROIC/WACCN/A
WACC6.47%
2.3 Liquidity
BAYN has a Current Ratio of 1.13. This is a normal value and indicates that BAYN is financially healthy and should not expect problems in meeting its short term obligations.
BAYN's Current ratio of 1.13 is on the low side compared to the rest of the industry. BAYN is outperformed by 67.27% of its industry peers.
BAYN has a Quick Ratio of 1.13. This is a bad value and indicates that BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
BAYN's Quick ratio of 0.73 is on the low side compared to the rest of the industry. BAYN is outperformed by 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
BAYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.72%.
Measured over the past years, BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.27% on average per year.
Looking at the last year, BAYN shows a decrease in Revenue. The Revenue has decreased by -2.16% in the last year.
BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
3.2 Future
The Earnings Per Share is expected to grow by 3.36% on average over the next years.
Based on estimates for the next years, BAYN will show a small growth in Revenue. The Revenue will grow by 1.49% on average per year.
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.36%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.49%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 5.71, the valuation of BAYN can be described as very cheap.
Based on the Price/Earnings ratio, BAYN is valued cheaply inside the industry as 98.18% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.31. BAYN is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 6.26, which indicates a rather cheap valuation of BAYN.
Based on the Price/Forward Earnings ratio, BAYN is valued cheaper than 96.36% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.59. BAYN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.71 | ||
| Fwd PE | 6.26 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BAYN indicates a somewhat cheap valuation: BAYN is cheaper than 78.18% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BAYN indicates a rather cheap valuation: BAYN is cheaper than 98.18% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.52 | ||
| EV/EBITDA | 9.37 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
5. Dividend
5.1 Amount
BAYN has a yearly dividend return of 0.41%, which is pretty low.
BAYN's Dividend Yield is slightly below the industry average, which is at 3.00.
Compared to an average S&P500 Dividend Yield of 2.40, BAYN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
5.2 History
The dividend of BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
The earnings of BAYN are negative and hence is the payout ratio. BAYN will probably not be able to sustain this dividend level.
DP-3.69%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
FRA:BAYN (11/28/2025, 7:00:00 PM)
30.485
-0.14 (-0.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap29.95B
Revenue(TTM)46.61B
Net Income(TTM)-3.42B
Analysts71.43
Price Target29.58 (-2.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-3.69%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.87%
Min EPS beat(2)1.86%
Max EPS beat(2)45.89%
EPS beat(4)3
Avg EPS beat(4)8.47%
Min EPS beat(4)-17.26%
Max EPS beat(4)45.89%
EPS beat(8)6
Avg EPS beat(8)3.46%
EPS beat(12)8
Avg EPS beat(12)1.61%
EPS beat(16)12
Avg EPS beat(16)4.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-0.98%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)3
Avg Revenue beat(12)-2.37%
Revenue beat(16)7
Avg Revenue beat(16)-1.04%
PT rev (1m)1.65%
PT rev (3m)1.99%
EPS NQ rev (1m)0.08%
EPS NQ rev (3m)-5.7%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-0.02%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.25%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-0.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.71 | ||
| Fwd PE | 6.26 | ||
| P/S | 0.65 | ||
| P/FCF | 6.52 | ||
| P/OCF | 4.19 | ||
| P/B | 0.99 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.37 |
EPS(TTM)5.34
EY17.52%
EPS(NY)4.87
Fwd EY15.98%
FCF(TTM)4.67
FCFY15.33%
OCF(TTM)7.28
OCFY23.87%
SpS47
BVpS30.91
TBVpS-18.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number60.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% | ||
| FCFM | 9.94% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score4
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Debt/EBITDA | 4.79 | ||
| Cap/Depr | 32.07% | ||
| Cap/Sales | 5.54% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 107.94% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 0.81 |
F-Score4
WACC6.47%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%137.5%
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.36%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-3.09%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.49%
EBIT growth 1Y-161.08%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.33%
EBIT Next 3Y21.52%
EBIT Next 5Y11.12%
FCF growth 1Y1068.78%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y169.98%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / BAYN.DE FAQ
What is the fundamental rating for BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to BAYN.DE.
What is the valuation status for BAYN stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (BAYN.DE). This can be considered as Undervalued.
How profitable is BAYER AG-REG (BAYN.DE) stock?
BAYER AG-REG (BAYN.DE) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for BAYN stock?
The Earnings per Share (EPS) of BAYER AG-REG (BAYN.DE) is expected to decline by -6.5% in the next year.
Is the dividend of BAYER AG-REG sustainable?
The dividend rating of BAYER AG-REG (BAYN.DE) is 0 / 10 and the dividend payout ratio is -3.69%.